Scolaris Content Display Scolaris Content Display

یوگا برای آسم

Contraer todo Desplegar todo

Referencias

منابع مطالعات واردشده در این مرور

Bidwell 2012 {published data only}

Bidwell AJ,  Yazel B,  Davin D,  Fairchild TJ,  Kanaley JA. Yoga training improves quality of life in women with asthma. Journal of Alternative and Complementary Medicine 2012;18(8):749‐55. CENTRAL

Cooper 2003 {published data only}

Cooper S,  Oborne J,  Newton S,  Harrison V,  Thompson Coon J,  Lewis S,  et al. Effects of two breathing exercises (Buteyko and pranayama) in asthma: a randomised controlled trial. Thorax 2003;58(8):674‐9. CENTRAL

Fluge 1994 {published data only}

Flüge T,  Richter J,  Fabel H,  Zysno E,  Weller E,  Wagner TO. Long‐term effects of breathing exercises and yoga in patients suffering from bronchial asthma. Pneumologie 1994;48(7):484‐90. CENTRAL

Kant 2013 {published data only}

Kant S, Agnihotri S. Asthma diagnosis and treatment ‐ 1029. Yoga as an adjuvant therapy in asthma management. The World Allergy Organization Journal 2013;6(Suppl 1):P28. CENTRAL

Lathadevi 2012 {published data only}

Lathadevi GV, Uma Maheswari T. Evaluation of pulmonary functions in asthmatics after six weeks of ujjayi pranayama and shavasana training. Biomedicine 2012;32(1):52‐6. CENTRAL

Mekonnen 2010 {published data only}

Mekonnen D, Mossie A. Clinical effects of yoga on asthmatic patients: a preliminary clinical trial. Ethiopian Journal of Health Sciences 2010;20(2):107‐12. CENTRAL

Nagarathna 1985 {published data only}

Nagarathna R, Nagendra HR. Yoga for bronchial asthma: a controlled study. British Medical Journal 1985;291(6502):1077‐9. CENTRAL

Prem 2013 {published data only}

Prem V, Sahoo RC, Adhikari P. Comparison of the effects of Buteyko and pranayama breathing techniques on quality of life in patients with asthma ‐ a randomized controlled trial. Clinical Rehabilitation 2013;27(2):133‐41. CENTRAL

Sabina 2005 {published data only}

Sabina AB,  Williams AL,  Wall HK,  Bansal S,  Chupp G,  Katz DL. Yoga intervention for adults with mild‐to‐moderate asthma: A pilot study. Annals of Allergy, Asthma and Immunology 2005;94(5):543‐8. CENTRAL

Satpathy 2012 {published data only}

Satpathy S, Kar A, Mishra A. A comparative study of effect of yoga and drugs on pulmonary functions and inflammation in bronchial asthma. International Journal of Basic and Applied Physiology 2012;2(1):12‐5. CENTRAL

Singh 1990 {published data only}

Singh V, Wisniewski A, Britton J, Tattersfield A. Effect of yoga breathing exercises (pranayama) on airway reactivity in subjects with asthma. The Lancet 1990;335(8702):1381‐3. CENTRAL

Singh 2012 {published data only}

Singh S, Soni R, Singh KP, Tandon OP. Effect of yoga practices on pulmonary function tests including transfer factor of lung for carbon monoxide (TLCO) in asthma patients. Indian Journal of Physiology and Pharmacology 2012;56(1):63‐8. CENTRAL

Sodhi 2009 {published data only}

Sodhi C, Singh S, Dandona PK. A study of the effect of yoga training on pulmonary functions in patients with bronchial asthma. Indian Journal of Physiology and Pharmacology 2009;53(2):169‐74. CENTRAL
Sodhi C,  Singh S,  Bery A. Assessment of the quality of life in patients with bronchial asthma, before and after yoga: a randomised trial. Iranian Journal of Allergy, Asthma and Immunology 2014;13(1):55‐60. CENTRAL

Vedanthan 1998 {published data only}

Vedanthan PK,  Kesavalu LN,  Murthy KC,  Duvall K,  Hall MJ,  Baker S, et al. Clinical study of yoga techniques in university students with asthma: a controlled study. Allergy and Asthma Proceedings 1998;19(1):3‐9. CENTRAL

Vempati 2009 {published data only}

Vempati R, Bijlani RL, Deepak KK. The efficacy of a comprehensive lifestyle modification programme based on yoga in the management of bronchial asthma: a randomized controlled trial. BMC Pulmonary Medicine 2009;9:37. CENTRAL

منابع مطالعات خارج‌شده از این مرور

Agnihotri 2014 {published data only}

Agnihotri S,  Kant S,  Kumar S,  Mishra RK,  Mishra SK. Impact of yoga on biochemical profile of asthmatics: A randomized controlled study. International Journal of Yoga 2014;7(1):17‐21. CENTRAL

Chen 2009 {published data only}

Chen TL,  Mao HC,  Lai CH,  Li CY,  Kuo CH. The effect of yoga exercise intervention on health related physical fitness in school‐age asthmatic children. Hu Li Tsa Chih ‐ Journal of Nursing 2009;56(2):42‐52. CENTRAL

Cowie 2008 {published data only}

Cowie RL,  Conley DP,  Underwood MF,  Reader PG. A randomised controlled trial of the Buteyko technique as an adjunct to conventional management of asthma. Respiratory Medicine 2008;102(5):726‐32. CENTRAL

Holloway 2007 {published data only}

Holloway EA, West RJ. Integrated breathing and relaxation training (the Papworth method) for adults with asthma in primary care: A randomised controlled trial. Thorax 2007;62(12):1039‐42. CENTRAL

Jain 1991 {published data only}

Jain SC, Rai L, Valecha A, Jha UK, Bhatnagar SO, Ram K. Effect of yoga training on exercise tolerance in adolescents with childhood asthma. Journal of Asthma 1991;28(6):437‐42. CENTRAL

Khanam 1996 {published data only}

Khanam AA, Sachdevaq U, Guleria R, Deepak KK. Study of pulmonary and autonomic functions of asthma patients after yoga training. Indian Journal of Physiology and Pharmacology 1996;40(4):318‐24. CENTRAL

Khare 1991 {published data only}

Khare KC, Sanghvi VC, Bhatnagar AD, Khare R. Effect of yoga in treatment of bronchial asthma. Indian Practitioner 1991;44(1):23‐7. CENTRAL

Kligler 2011 {published data only}

Kligler B,  Homel P,  Blank AE,  Kenney J,  Levenson H,  Merrell W. Randomized trial of the effect of an integrative medicine approach to the management of asthma in adults on disease‐related quality of life and pulmonary function. Alternative Therapies in Health and Medicine 2011;17(1):10‐5. CENTRAL

Manocha 2002 {published data only}

Manocha R, Marks GB, Kenchington P, Peters D, Salome CM. Sahaja yoga in the management of moderate to severe asthma: A randomised controlled trial. Thorax 2002;57(2):110‐5. CENTRAL

Sathyaprabha 2001 {published data only}

Sathyaprabha TN, Murthy H, Murthy BT. Efficacy of naturopathy and yoga in bronchial asthma ‐ a self controlled matched scientific study. Indian Journal of Physiology and Pharmacology 2001;45(1):80‐6. CENTRAL

Saxena 2009 {published data only}

Saxena T, Saxena M. The effect of various breathing exercises (pranayama) in patients with bronchial asthma of mild to moderate severity. International Journal of Yoga 2009;2(1):22‐5. CENTRAL

Tahan 2014 {published data only}

Tahan F,  Eke Gungor H,  Bicici E. Is yoga training beneficial for exercise‐induced bronchoconstriction?. Alternative Therapies in Health and Medicine 2014;20(2):18‐23. CENTRAL

Adams 2004

Adams RJ, Wilson DH, Taylor AW, Daly A, Tursan d'Espaignet E, Dal Grande E, et al. Psychological factors and asthma quality of life: a population based study. Thorax 2004;59:930‐5.

Anand 1991

Anand BK. Yoga and medical sciences. Indian Journal of Physiology and Pharmacology 1991;35:84‐7.

Barker 2013

Barker NJ,  Jones M,  O'Connell NE,  Everard ML. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in children. Cochrane Database of Systematic Reviews 2013, Issue 12. [DOI: 10.1002/14651858.CD010376.pub2]

Bateman 2015

Bateman ED, Esser D, Chirila C, Fernandez M, Fowler A, Moroni‐Zentgraf P, et al. Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta‐analysis. Journal of Allergy and Clinical Immunology 2015;136:914‐22.

Becker 2003

Becker A, Lemière C, Bérubé D, Boulet LP, Ducharme FM, FitzGerald M, et al. Summary of recommendations from the Canadian Asthma Consensus Guidelines. CMAJ 2005;173:S3‐11.

Boehm 2012

Boehm K,  Ostermann T,  Milazzo S,  Büssing A. Effects of yoga interventions on fatigue: a meta‐analysis. Evidence‐Based Complementary and Alternative Medicine 2012;2012:124703.

Bowler 1998

Bowler SD, Green A, Mitchell CA. Buteyko breathing techniques in asthma: a blinded randomised controlled trial. Medical Journal of Australia 1998;169:575‐8.

Bukowski 2007

Bukowski EL, Conway A, Glentz LA, Kurland K, Galantino ML. The effect of Iyengar yoga and strengthening exercises for people living with osteoarthritis of the knee: a case series. International Quarterly of Community Health Education 2007;26:287‐305.

Bulavin 1993

Bulavin VV, Kliuzhev VM, Kliachkin LM, Lakshmankumar, Zuikhin ND, Vlasova TN. Elements of yoga therapy in the combined rehabilitation of myocardial infarct patients in the functional recovery period. Voprosy Kurortologii, Fizioterapii, i Lechcbnoi Fizicheskoi Kultury 1993;4:7‐9.

Burgess 2011

Burgess J,  Ekanayake B,  Lowe A,  Dunt D,  Thien F,  Dharmage SC. Systematic review of the effectiveness of breathing retraining in asthma management. Expert Review of Respiratory Medicine 2011;5:789‐807.

Chew 1999

Chew FT, Goh DY, Lee BW. The economic cost of asthma in Singapore. Australian and New Zealand Journal of Medicine 1999;29:228‐33.

Chowdhary 1999

Chowdhary R, Singh V, Tattersfield AE, Sharma SD, Kar S, Gupta AB. Relationship of flow and cross‐sectional area to frictional stress in airway models of asthma. Journal of Asthma 1999;36:R419‐26.

Clarke 2015

Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002‐2012. National Health Statistics Reports; no 79. Hyattsville, MD: National Center for Health Statistics, 2015.

Cramer 2014

Cramer H,  Posadzki P,  Dobos G,  Langhorst J. Yoga for asthma: a systematic review and meta‐analysis. Annals of Allergy, Asthma and Immunology 2014;112:503‐10.

Crofton 1975

Crofton J, Douglas A. Respiratory Diseases. 2nd Edition. Oxford: Blackwell Scientific Publications, 1975.

Culos‐Reed 2006

Culos‐Reed SN, Carlson LE, Daroux LM, Hately‐Aldous S. A pilot study of yoga for breast cancer survivors: physical and psychological benefits. Psycho‐Oncology 2006;15:891‐7.

DiStasio 2008

DiStasio SA. Integrating yoga into cancer care. Clinical Journal of Oncology Nursing 2008;12:125‐30.

Donesky‐Curenco 2009

Donesky‐Curenco D, Nguyen HQ, Paul S, Carrier‐Kohlman V. Yoga therapy decreases dyspnea‐related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study. The Journal of Alternative and Complementary Medicine 2009;15:225‐34.

Eichenberger 2013

Eichenberger PA,  Diener SN,  Kofmehl R,  Spengler CM. Effects of exercise training on airway hyperreactivity in asthma: a systematic review and meta‐analysis. Sports Medicine 2013;43:1157‐70.

Galantino 2008

Galantino ML,  Galbavy R,  Quinn L. Therapeutic effects of yoga for children: a systematic review of the literature. Pediatric Physical Therapy 2008;20:66‐80.

Global Initiative for Asthma 2011

Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. http://www.ginasthma.orgUpdated 2011.

Goyeche 1982

Goyeche JR, Abo Y, Ikemi Y. Asthma: the yoga perspective. Part II: yoga therapy in the treatment of asthma. Journal of Asthma Research 1982;19:189‐201.

Groessl 2008

Groessl EJ, Weingart KR, Aschbacher K, Pada L, Naxi S. Yoga for veterans with chronic low‐back pain. The Journal of Alternative and Complementary Medicine 2008;14:1123‐9.

Guyatt 2008

Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schünemann HJ, et al. Rating quality of evidence and strength of recommendations: What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336:995‐8.

Harris Interactive Service Bureau 2008

Harris Interactive Service Bureau, Yoga Journal. Yoga in America 2008. http://www.yogajournal.com/advertise/press_releases/10 (accessed 26 February 2012).

Higgins 2011

Higgins JPT, Green S(editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Holloway 2004

Holloway EA, Ram FSF. Breathing exercises for asthma. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD001277.pub2]

ISAAC 2006

Asher MI, Montefore S, Bjorksten B, Lai C, Strachan DP, Weilland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross‐sectional surveys. The Lancet 2006;368:733‐43.

Jain 1993

Jain SC, Uppal A, Bhatnagar SO, Talukdar B. A study of response pattern of non‐insulin dependent diabetics to yoga therapy. Diabetes Research and Clinical Practice 1993;19:69‐74.

Jones 2002

Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory Journal 2002;19:398‐404.

Juniper 1994

Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease‐specific Quality of Life Questionnaire. Journal of Clinical Epidemiology 1994;47:81‐7.

Kappmeier 2006

Kappmeier KL, Ambrosini DM. Instructing Hatha Yoga. Champaign, IL: Human Kinetics, 2006.

Kesterson 1989

Kesterson J, Clinch N. Metabolic rate, respiratory exchange ratio and apneas during meditation. American Journal of Physiology 1989;256:632‐8.

Lamb 2006

Lamb T. Yoga statistics and demographics. http://www.iayt.org/site_vx2/publications/Bibliographies_Members/stats.pdf (accessed 25 November 2012).

Lorenc 2014

Lorenc AB,  Wang Y,  Madge SL,  Hu X,  Mian AM,  Robinson N. Meditative movement for respiratory function: a systematic review. Respiratory Care 2014;59:427‐40.

Masoli 2004

Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469‐78.

McCall 2013

McCall MC,  Ward A,  Roberts NW,  Heneghan C. Overview of systematic reviews: yoga as a therapeutic intervention for adults with acute and chronic health conditions. Evidence‐Based Complementary and Alternative Medicine 2013;2013:945895. [DOI: 10.1155/2013/945895]

Miller 2001

Miller AL. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Alternative Medicine Review 2001;6:20‐47.

Nayak 2004

Nayak NN,  Shankar K. Yoga: a therapeutic approach. Physical Medicine & Rehabilitation Clinics of North America 2004;15:783‐98.

NCCAM 2012

NCCAM. Asthma and complementary health practices. http://nccam.nih.gov/health/asthma/facts (accessed 25 November 2012).

O'Connor 2012

O'Connor E,  Patnode CD,  Burda BU,  Buckley DI,  Whitlock EP. Breathing exercises and/or retraining techniques in the treatment of asthma: comparative effectiveness [Internet]. http://www.ncbi.nlm.nih.gov/books/NBK109355/pdf/Bookshelf_NBK109355.pdf (accessed 10 March 2016).

Opat 2000

Opat AJ, Cohen MM, Bailey MJ, Abramson MJ. A clinical trial of the Buteyko breathing technique in asthma as taught by a video. Journal of Asthma 2000;37:557‐64.

Ozgen Alpaydin 2011

Ozgen Alpaydin A, Yorgancioğlu A, Yilmaz O, Bora M, Göktalay T, Celik P, et al. Validity and reliability of "Asthma Quality of Life Questionnaire" in a sample of Turkish adult asthmatic patients. Tuberkuloz ve Toraks 2011;59:321‐7.

Patel 1975

Patel C, North WR. Randomised controlled trial of yoga and bio‐feedback in management of hypertension. The Lancet 1975;2:93‐5.

Penman 2008

Penman SJ. Yoga in Australia: results of a national survey. http://researchbank.rmit.edu.au/eserv/rmit:6110/Penman.pdf (accessed 25 November 2012).

Peters 2006

Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respiratory Medicine 2006;100:1139‐51.

Posadzki 2011

Posadzki P, Ernst E. Yoga for asthma? A systematic review of randomized clinical trials. Journal of Asthma 2011;48:632–9.

Ramaratnam 2000

Ramaratnam S, Sridharan K. Yoga for epilepsy. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD001524]

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Riley 2004

Riley D. Hatha yoga and the treatment of illness. Alternative Therapies in Heath and Medicine 2004;10:20‐1.

Shivpuri 1974

Shivpuri DN. Studies on methods of clinical research in bronchial asthma and allied conditions. Aspects of Allergy and Applied Immunology 1974;7:15‐35.

Solway 1997

Solway J, Fredberg J. Perhaps airway smooth muscle dysfunction contributes to asthmatic bronchial hyperresponsiveness after all. American Journal of Respiratory Cell and Molecular Biology 1997;17:144‐6.

Stock 2005

Stock S, Redaelli M, Luengen M, Wendland G, Civello D, Lauterbach KW. Asthma: prevalence and cost of illness. European Respiratory Journal 2005;25:47‐53.

Sudsuang 1991

Sudsuang R, Chentanez V, Veluvan K. Effect of Buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time. Physiology and Behavior 1991;50:543‐8.

Sundar 1984

Sundar S, Agarwal SK, Singh VP, Bhattacharya SK, Udupa KN, Vaish SK. Role of yoga in management of essential hypertension. Acta Cardiologica 1984;39:203‐8.

Szucs 1999

Szucs TD, Anderhub H, Rutishauser M. The economic burden of asthma: direct and indirect costs in Switzerland. European Respiratory Journal 1999;13:281‐6.

Tekur 2008

Tekur P, Singhow C, Nagendra HR, Raghuram N. Effect of short‐term intensive yoga program on pain, functional disability, and spinal flexibility in chronic low back pain: a randomized control study. Journal of Alternative and Complementary Medicine 2008;14:637‐44.

Thomas 2003

Thomas M, McKinley RK, Freeman E, Foy C, Prodger P,  Price D. Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial. Thorax 2003;58:110‐5.

Van Lieshout 2008

Van Lieshout RJ, MacQueen G. Psychological factors in asthma. Allergy, Asthma, and Clinical Immunology 2008;4:12‐28.

van Montfrans 1990

van Montfrans GA, Karemaker JM, Wieling W, Dunning AJ. Relaxation therapy and continuous ambulatory blood pressure in mild hypertension: a controlled study. BMJ 1990;300:1368‐72.

Visweswaraiah 2004

Visweswaraiah NK, Telles S. Randomized trial of yoga as a complementary therapy for pulmonary tuberculosis. Respirology 2004;9:96‐101.

Weiss 2001

Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. The Journal of Allergy and Clinical Immunology 2001;107:3‐8.

Yawn 2008

Yawn BP. Factors accounting for asthma variability: achieving optimal symptom control for individual patients. Primary Care Respiratory 2008;17:138‐47.

Yoga Journal 2015

Yoga Journal. By the numbers: yoga stats that may surprise you. http://www.yogajournal.com/article/yoga‐journal‐40th‐anniversary/yoga‐numbers‐yoga‐statistics/ (accessed 12 March 2016).

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Bidwell 2012

Methods

  • Country: United States

  • Setting: research laboratory/center based in Syracuse University, and resident homes of the participants

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: Quote: "a forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) ratio of < 80% of predicted, use of a bronchodilator at least once daily, and symptoms of wheezing and/or coughing for a minimum of 2 years that improves either spontaneously or with drug therapy."

  • Exclusion criteria: Quote: "Subjects were excluded if they were smokers (smoking ≥ 2 cigarettes/day), participated in yoga therapy in the previous 12 months, were diagnosed as having hypertension, major orthopedic injuries prohibiting the performance of various yoga postures, and/or currently taking any medications that would alter autonomic function (e.g., b‐blockers)."

  • No. of participants: 19

  • Age (years) (range, mean/median): 20 to 65, 42

  • Female (%): 100

  • White (%): not reported

  • Mean duration of asthma: not reported

  • Severity of asthma: mild to moderate

Interventions

Yoga group (n = 12): 20 x 1‐hour in‐class yoga sessions in a group setting (2 times per week for 10 weeks) and 10 x 30‐minute sessions at home (1 time per week for 10 weeks)

  • Each class consisted of 10 minutes of relaxation/deep breathing, 40 minutes of various asanas (postures), and finished with 10 minutes of meditation to control stress levels. The yoga asanas included forward and backward bends, isometric lunges, balance poses, and static stretching, all part of a traditional Hatha yoga practice. The home session was based on a written lesson plan (5 minutes of deep breathing, 20 minutes of asanas, and 5 minutes of meditation and relaxation).

  • There was a 98% compliance rate for participants attending and participating in the in‐class yoga sessions and 100% compliance for the home sessions, as reported by a brief questionnaire given on a weekly basis.

Control group (n = 8): usual care

  • Participants were instructed not to participate in any yoga or related breathing practices for the duration of the study. In addition, they were instructed not to begin any new activities, but simply to follow the guidelines provided by their physicians.

  • Participants were questioned about adherence to these instructions; all stated that they had been compliant.

Outcomes

  • Outcome(s): quality of life (SGRQ), FEV1, FVC, PEFR, tidal volume

  • Assessment time point(s): 10 weeks

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. The participants' knowledge of their assignment status could subconsciously affect their performance, especially in more subjective measures such as quality of life. Lung function measures may more determined by the biological, objective effects of the intervention and therefore less vulnerable to performance bias irrespective of blinding. Overall, we assessed this study to be at high risk of performance bias

Blinding of outcome assessment (detection bias)
All outcomes

High risk

No active control and no procedure intended to blind outcome assessors were mentioned. In the case of self reported outcomes such as quality of life, the participant is the outcome assessor and therefore knowledge of assignment status could affect the outcome. Objective measures such as lung function may be less vulnerable to detection bias irrespective of blinding. Overall, we assessed this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

No information on withdrawal or loss to follow‐up of participants was provided

Selective reporting (reporting bias)

High risk

The pre‐post changes in FEV1, PEFR, and FVC of the 2 groups were measured but not reported in detail due to lack of statistical significance. Quote: "There were no differences in FEV1, FVC, or PEFR in either group prior to the intervention, and no changes were demonstrated after the intervention."

Other bias

Low risk

No evidence of other bias was found

Cooper 2003

Methods

  • Country: United Kingdom

  • Setting: Nottingham City Hospital and resident homes of participants

  • Design: a randomised, placebo‐controlled, parallel‐group trial

Participants

  • Inclusion criteria: taking an inhaled short‐acting beta2 agonist at least twice a week and regular inhaled corticosteroids with no change in dose in the preceding 4 weeks; pre‐bronchodilator FEV1 of at least 50% predicted and a 10% increase following 400 mg inhaled salbutamol; a provocative dose of methacholine causing a 20% fall in FEV1 (PD20) of 10.24 mmol or less; and a mean daily symptom score of 1 or more during the run‐in period

  • Exclusion criteria: people taking treatment other than sodium cromoglycate

  • No. of participants: 59

  • Age (years) (range, mean/median): 18 to 70, 46

  • Female (%): 43

  • White (%): not reported

  • Mean duration of asthma: 23 years

  • Severity of asthma: "stable asthma", without details

Interventions

Participants were asked to keep their dose of inhaled steroid constant throughout the first 6 months, unless they had an asthma exacerbation.

Yoga group (n = 30): 15‐minute home use of Pink City Lung Exerciser twice a day for 6 months

  • Steroid reduction was attempted.

  • They were told to use their beta2 agonist only for symptom relief.

Control group (n = 29): 15‐minute home use of placebo Pink City Lung Exerciser twice a day for 6 months

Outcomes

  • Outcome(s): quality of life (SF‐36, AQLQ), symptom score, FEV1, asthma exacerbation rates, bronchodilator use, reduction in inhaled corticosteroid dose

  • Assessment time point(s): 6 months

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Eligible subjects were then allocated to one of the three treatment groups using the next available number from computer generated numbers, randomised in blocks of six, and using sealed envelopes prepared independently."

Allocation concealment (selection bias)

Low risk

Quote: "Eligible subjects were then allocated to one of the three treatment groups using the next available number from computer generated numbers, randomised in blocks of six, and using sealed envelopes prepared independently."

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Participants were blinded to some degree (quote: "Subjects were only given details of their treatment"). In addition, this is a placebo‐controlled trial in which participants were unlikely to determine the differences between groups. We thus considered the outcomes assessed in this study to be at low risk of performance bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "The assessor was not told which breathing technique subjects were using and subjects were asked not to mention it." For participant‐reported outcomes, the participant, who was unaware of group assignment, was the outcome assessor. We thus considered this study to be at low risk of performance bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Although 13 of the initially randomised 59 participants discontinued the study and were thus not included in the final analysis, "the number of participants failing to complete and the reasons given were similar" between groups. Specifically, of the 29 participants allocated PCLE placebo device, 7 discontinued (6 lack of time/no perceived benefit, 1 no reason given); of the 30 participants allocated PCLE, 6 discontinued (5 lack of time/no perceived benefit, 1 health reasons (eye problems))

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

Low risk

No evidence of other bias was found

Fluge 1994

Methods

  • Country: Germany

  • Setting: Medical College of Hanover, Department of Physical Medicine and Rehabilitation and Department of Pneumology

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: not reported

  • Exclusion criteria: smokers, indication of previous cardiopulmonary complications of bronchial asthma, acute exacerbation 8 weeks before baseline, other internal medicine conditions, people undergoing oral corticoid therapy

  • No. of participants: 24

  • Age (years) (range, mean/median): 21 to 55, 40.8

  • Female (%): 61

  • White (%): not reported

  • Mean duration of asthma: not reported

  • Severity of asthma: varied

Interventions

Yoga group (n = 12): 3‐hour sessions 5 times per week for 3 weeks of yoga (postures, breathing, cleansing, relaxation)

  • Yoga

  • Asana and Asana series

  • Mudra

  • Pranayama

  • Kriya

  • Yoga Nidra

Control group (n = 12): usual care

Outcomes

  • Outcome(s): VC, FEV1, TLC, FRC, RV, resistance Rtot, adverse events

  • Assessment time point(s): 1, 2, 3, 4 months

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. This study may be less vulnerable to performance bias as the only outcomes measured were lung function and adverse events, which may be more determined by the biological, objective effects of the intervention and therefore less likely to be affected by the participants' and/or personnel's awareness of the intervention status. However, we assessed this study to be at high risk of performance bias overall

Blinding of outcome assessment (detection bias)
All outcomes

High risk

The paper did not mention any procedures intended to blind outcome assessors. Even if no blinding was applied, assessments of lung function by spirometry are less likely to be biased by outcome assessors' awareness of the intervention status. Adverse event recording may be more at risk of bias from knowledge of participant's group assignment. Overall, we assessed this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

High risk

3 participants in the control group discontinued, and "their lung function measurements were not included in further evaluation". Although "no significant changes were discernible between the baseline values of these three and those of others", there could still be a high risk of bias because the sample size was so small (12 in the yoga group versus 12 in the control group). In addition, the 3 participants who withdrew did so for asthma‐related reasons. Quote: "Three subjects from the control group had to undergo treatment oral steroids use due to acute exacerbations of their asthma". The final results of the trial were thus prone to bias

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

Low risk

No evidence of other bias was found

Kant 2013

Methods

  • Country: India

  • Setting: Department of Pulmonary Medicine, King George's Medical University, Lucknow, India

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: (1) Mild‐to‐moderate persistent bronchial asthma severity according to Global Initiative for Asthma (GINA)‐2009; (2) Reversible airflow limitation measured by ≥ 12% increase and ≥ 200 mL absolute increase in FEV1 after postbronchodilator; (3) Non‐smokers or ex‐smokers with < 10 pack/year who have not smoked for at least 6 months; (4) Age between 12 and 60 years.

  • Exclusion criteria: (1) Those who had a clinical diagnosis of asthma but did not satisfy the diagnostic criteria; (2) People with severe airflow limitation or more (FEV1 < 60%); (3) Pregnant/lactating women; (4) Associated chronic respiratory diseases such as pulmonary tuberculosis and autoimmune lung diseases; (5) Major psychiatric illnesses.

  • No. of participants: 276

  • Age (years) (range, mean/median): 12 to 50, 38

  • Female (%): 57

  • White (%): not reported

  • Mean duration of asthma: not reported

  • Severity of asthma: mild to moderate

Interventions

Yoga group (n = 138): yogic intervention for 30 min per day in the morning, 5 days a week for a period of 6 months, in addition to standard medical treatment

  • Asanas

  • Pranayama

  • Meditation

Control group (n = 138): standard medical treatment

Outcomes

  • Outcomes: asthma quality of life score, asthma symptom score, "pulmonary functions" (without any details), asthma medication usage (inhalation therapy)

  • Assessment time point(s): 0, 3, 6 months

Notes

1. This study is available as abstract only. No details of the results were provided.

2. 17 participants in the yoga group and 18 participants in the control group dropped out during the study. The results presented in this report are based on the data collected from the 241 participants who completed the study

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote "A total of 276 subjects were included in the study after randomization which was done by computer generated random number table."

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. The participants' knowledge of the assignment status could subconsciously affect their quality of life, asthma symptom score, and asthma medication usage and to a lesser extent, their performance on lung function tests

Blinding of outcome assessment (detection bias)
All outcomes

High risk

The paper did not mention any procedures intended to blind outcome assessors. Even if no blinding was applied, assessments of lung function by spirometry were less likely to be biased by outcome assessors' knowledge of the assignment status. However, for participant‐reported outcomes such as quality of life, symptom score, and asthma medication usage, the participant, who was aware of assignment status, is the outcome assessor. Overall, we assessed this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

17 participants in the yoga group and 18 participants in the control group dropped out during the study. The results presented in this report are based on the data collected from the 241 participants who completed the study only. No information was provided regarding the characteristics and outcomes of the participants who dropped out

Selective reporting (reporting bias)

Low risk

All study outcomes were mentioned in the report, although no details were provided

Other bias

Low risk

No evidence of other bias was found

Lathadevi 2012

Methods

  • Country: India

  • Setting: the pulmonology outpatient department of PSG hospital

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: people with mild obstruction who were using bronchodilators intermittently (on and off)

  • Exclusion criteria: people with other lung disorders, tuberculosis, smokers, and acute exacerbation of asthmatic attack

  • No. of participants: 48

  • Age (years) (range, mean/median): 18 to 60, not reported

  • Female (%): 0

  • White (%): not reported

  • Mean duration of asthma: not reported

  • Severity of asthma: mild

Interventions

Yoga group (n = 24): 20‐minute session of ujjayi pranayama (postures and breathing) and shavasana (relaxation) twice a day for 6 weeks

  • All medications were fully stopped during the study.

Control group (n = 24): no intervention

  • The participants did not practice pranayama or shavasana.

  • All medications were fully stopped during the study

Outcomes

  • Outcome(s): FEV1, FVC, FEV1/FVC, PEFR

  • Assessment time point(s): 6 weeks

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. However, this study may be less vulnerable to performance bias as the only outcome measured was lung function, which may be more determined by the biological, objective effects of the intervention and therefore less likely to be affected by the participants' and/or personnel's awareness the intervention status. Despite this, we assessed this study to be at high risk of performance bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

The paper did not mention any procedures intended to blind outcome assessors. Even if no blinding was applied, assessments of lung function by spirometry are less likely to be biased by outcome assessors' awareness of the intervention status. For this reason, we judged this study to be at low risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Table 1 indicates no withdrawal or loss to follow‐up

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

Low risk

No evidence of other bias was found

Mekonnen 2010

Methods

  • Country: Ethiopia

  • Setting: the missionary of charity in Jimma town, southwest Ethiopia

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: People who were diagnosed at hospital level to have bronchial asthma; on regular follow‐up at chest clinic; with mild‐to‐moderate asthma; and who were able to come to the missionary of the charity for the yoga practice were included in the study based on their consent.

  • Exclusion criteria: People who refused to abide by the agreement; those with chronic obstructive lung disease; those with associated lung disease (diagnosed with active tuberculosis); those with severe asthmatic attack so that they could not sit comfortably to do the yoga practice; and diagnosed to have cardiac disease.

  • No. of participants: 24

  • Age (years) (range, mean/median): 11 to 51, 30.5

  • Female (%): 50

  • White (%): 0

  • Mean duration of asthma: 4 years

  • Severity of asthma: mild

Interventions

Yoga group (n = 12): 50‐minute daily sessions of yoga (postures, breathing, relaxation, discussion) for 4 weeks; remained on normal medication.

  • integrated yogic practice: 5‐minute loosening exercise

  • yogic postures: 10‐minute general physical postures; 10‐minute deep relaxation practice

  • breath‐slowing technique: 10 minutes

  • discussion: 10 minutes

  • salbutamol use was allowed

Control group (n = 12): not reported; remained on normal medication

Outcomes

  • Outcome(s): asthma attacks per week, rescue inhaler use, PEFR

  • Assessment time point(s): 4 weeks

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Quote: "Participants were given information about the study objective, voluntary participation and told to their treatment. They were also told about the activities that are going to be practiced and were also informed as they can withdraw from participation at any stage." No active control. In this case, participants' knowledge of the assignment status could subconsciously affect their asthma medication usage and to a lesser extent their reporting of asthma attacks and their performance in lung function tests such as PEFR

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Quote: "A physician who was blinded to the groups helped to complete the questionnaire and conducted the peak expiratory flow meter test." However, as asthma medication use and asthma attacks per week are likely to be self reported subjective outcomes, and participants were aware of group allocation, we considered this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

The tables indicate no withdrawal or loss to follow‐up

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

High risk

A number of 'errors' were found in the paper, e.g. inconsistent data in table 2 and table 4. This raises concern about the quality, i.e. at least the reporting quality, of the study

Nagarathna 1985

Methods

  • Country: India

  • Setting: Vivekananda Kendra Yoga Therapy and Research Centre

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: people with established bronchial asthma satisfying the clinical criteria of Crofton and Douglas, Crofton 1975, and Shivpuri, Shivpuri 1974

  • Exclusion criteria: not reported

  • No. of participants: 106

  • Age (years) (range, mean/median): 9 to 47, 26.4

  • Female (%): 28%

  • White (%): not reported

  • Mean duration of asthma: not reported

  • Severity of asthma: not reported

Interventions

Yoga group (n = 53): 2.5‐hour sessions of yoga training programme (postures, breathing, meditation, lectures) daily for 2 weeks; 65‐minutes yoga daily for 54 months

  • breathing exercises: 5 minutes

  • sithilikarana, zyayama, and suryanamaskar: 5 minutes

  • yogasanas: (a) general yogasanas (20 minutes); (b) savasana (10 minutes)

  • pranayama: 10 minutes

  • meditation and devotional session: 15 minutes

  • kriyas: weekly

  • lectures and discussions

  • continued taking their usual drugs (bronchodilators) during the study

Control group (n = 53): usual care (continued taking their usual drugs)

Outcomes

  • Outcome(s): asthma attacks per week, severity score, PEFR, drug treatment score

  • Assessment time point(s): 54 months (PEFR and drug treatment score were measured every 6 months from immediately after intervention to 54 months after intervention)

Notes

25 participants dropped out of the study: 7 after 6 months' of follow‐up, 7 after 12 months, 2 after 18 months, 4 after 24 months, and 5 after 30 months

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

This is more like a matched cohort study than a RCT. The two groups of participants were balanced on the matched factors, but not necessarily on others. The randomisation was conducted separately within every pair of two participants, i.e. it was conducted a total of 53 times, once for each pair. However, to randomise or to just subjectively assign two participants for each pair into different groups is the same in terms of potential to introduce bias, because other factors than the matched ones could not be balanced in this way. Quote: "Fifty three pairs of patients matched for age and sex and type, severity, and duration of asthma were selected from a bigger group who came to our outpatient clinic for yoga therapy. One from each pair was randomly selected for training in yoga, and the other served as a control."

Allocation concealment (selection bias)

High risk

After the assignment status of 1 participant in a pair was determined, the intervention to be received by the other member of the pair, who had not been recruited, was determined. Whether or not to recruit a coming patient could thus be affected by the staff's knowledge of the assignment scheme, which could lead to selection bias

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. The participants' knowledge of the assignment status could subconsciously affect their asthma medication usage and asthma severity score and to a lesser extent their reporting of asthma attacks and performance on lung function tests

Blinding of outcome assessment (detection bias)
All outcomes

High risk

The paper did not mention any procedures intended to blind the outcome assessment, and in the case of participant‐reported outcomes such as asthma severity score and medication usage, the participant, who was aware of group assignment, is the outcome assessor. We therefore assessed this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Although 25 participants (24%) dropped out at the end of the study, their outcomes were still recorded. In this review we used records that covered almost all participants

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

Low risk

No evidence of other bias was found

Prem 2013

Methods

  • Country: India

  • Setting: outpatient department of chest medicine, Manipal Hospital

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: Aged between 18 and 60 years, AQLQ score < 5.5, FEV1 increase by 12% following bronchodilator administration, usage of bronchodilator for 6 months, and no exacerbation in the preceding 8 weeks.

  • Exclusion criteria: People were excluded if they had medical conditions impairing ability to perform breathing techniques, had previous history of breathing retraining, were pregnant, and non‐compliance with exercise for more than 15% of study period.

  • No. of participants: 80

  • Age (years) (range, mean/median): 18 to 60, 38

  • Female (%): 59

  • White (%): not reported

  • Mean duration of asthma: 11 years

  • Severity of asthma: not reported

Interventions

Yoga group (n = 40): pranayama yoga breathing: 60 minutes each day for 3 to 5 days, and then during the 3 months' follow‐up practice the exercises at home for 15 minutes twice daily; take medications in accordance with the physician's instructions

Control group (n = 40): usual care (routine pharmacological management)

Outcomes

  • Outcome(s): Asthma Control Questionnaire, AQLQ, FEV1, FEV1/FVC ratio, adverse events

  • Assessment time point(s): 3 months

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Low risk

Quote: "The method of allocation was concealed in sequentially numbered, sealed, opaque envelopes. An independent observer who performed the randomisation procedure was not involved in conducting intervention and collecting the outcome measures."

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. The participants' knowledge of the assignment status could subconsciously affect their quality of life and asthma control, and to a lesser extent, their reporting of adverse events and their performance in lung function tests

Blinding of outcome assessment (detection bias)
All outcomes

High risk

The paper did not mention any procedures intended to blind outcome assessment. Even if no blinding was applied, assessments of lung function by spirometry and adverse events may be less likely to be biased by participant's and/or outcome assessors' knowledge of the assignment status, while participant‐reported outcomes are at higher risk of bias. Overall, we assessed this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

4 participants from the yoga group were excluded from analysis due to non‐compliance with exercise. The baseline characteristics of the 4 participants were not presented or compared with those of other participants in the yoga group. However, compared to the sample size of 80, the drop‐out rate was low. We thus considered the risk of bias arising from this issue to be low

Selective reporting (reporting bias)

High risk

Adverse events were recorded but not reported. Quote: "Exacerbations and adverse events were recorded for all the groups."

Other bias

Low risk

No evidence of other bias was found

Sabina 2005

Methods

  • Country: United States

  • Setting: The Yale‐Griffin Prevention Research Center

  • Design: a double‐blind, randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: (1) 18 years of age or older; (2) an established diagnosis of mild‐to‐moderate asthma for at least 6 months; (3) taking at least 1 of the following: inhaled beta2 agonists, methylxanthines, anticholinergics, inhaled corticosteroids, leukotriene inhibitors or receptor antagonists, or mast cell‐stabilising agents for at least 6 months; and (4) stable medication dosing for the past month.

  • Exclusion criteria: (1) smoked currently (or in the past year) or had a smoking history of greater than 5 pack‐years; (2) had a concomitant lung disease; (3) had only exercise‐induced asthma; (4) practiced yoga in the past 3 years; (5) were pregnant; (6) had a chronic medical condition that required treatment with oral corticosteroids in the past month; (7) had a medical condition that contraindicated exercise; or (8) had an unstable medical condition.

  • No. of participants: 62

  • Age (years) (range, mean/median): 18 to 76, 51

  • Female (%): 74

  • White (%): 84

  • Mean duration of asthma: > 6 months

  • Severity of asthma: mild to moderate

Interventions

Yoga group (n = 29): 90‐minute sessions twice weekly for 4 weeks of Iyengar yoga, including 15 asanas (postures), pranayama (breathing), and dhyana (meditation); rescue inhaler use was allowed.

Control group (n = 33): 90‐minute sessions twice weekly for 4 weeks of sham intervention of basic muscle stretching exercises; rescue inhaler use was allowed

Outcomes

  • Outcome(s): Mini Asthma Quality of Life Questionnaire, rescue inhaler use, FEV1, FVC, FEV1/FVC, FEV 25‐75%, symptom diaries, healthcare utilisation, adverse events

  • Assessment time point(s): 4, 16 weeks

Notes

  • Intention‐to‐treat analysis was performed.

  • Compliance: Mean treatment compliance and class attendance did not differ significantly between treatment groups. Compliance rates declined for both groups as the study progressed, with a statistically significant decline in compliance from week 4 (the first time compliance was evaluated) in the intervention group to 12 weeks (P = 0.02) and 16 weeks (P = 0.003) of follow‐up

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "In the interest of maintaining small class sizes for the intervention, participants were divided into 5 consecutive cohorts. In each cohort, participants were randomly assigned on the basis of software generated (SAS version 8.2; SAS Institute Inc, Cary, NC) blocked random assignment to a yoga intervention group or a stretching control group."

Allocation concealment (selection bias)

Low risk

Quote: "At enrolment, each participant was assigned an identification number, which was later coded to his or her allocation. All allocations were maintained in sealed envelopes that were unavailable to outcomes assessors to maintain masking."

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

This is a double‐masked controlled clinical trial. Quote: "all participants were told that they were receiving 'complementary care body conditioning' for asthma management, and Sanskrit words, including yoga, asana, pranayama, and dhyana, were not used with participants." We therefore considered participants to be unaware of group assignment status and the study to be at low risk of performance bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Outcomes were evaluated at baseline, at the end of the training sessions, and then monthly for 3 months by an investigator masked to treatment assignment." Participant‐reported outcomes were also considered to be at low risk of bias as the participants were unaware of group assignment

Incomplete outcome data (attrition bias)
All outcomes

High risk

17 participants (27%) withdrew, 6 on yoga and 11 on control. Intention‐to‐treat analysis was performed, but there remains a risk of attrition bias inflating the results as more participants withdrew on control

Selective reporting (reporting bias)

High risk

Details on results of secondary outcomes were not reported

Other bias

High risk

The baseline FEV1/FVC (P = 0.02) and FEV 25‐75% (P = 0.03) were not comparable between intervention and control groups. Quote: "Although not all baseline values were significantly different, the intervention group consistently exhibited more disability for all spirometry measurements and asthma severity assessments than controls."

Satpathy 2012

Methods

  • Country: India

  • Setting: Department of Physiology and Department of Pulmonary Medicine in VSS Medical College, Burla, India

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: (1) cases of bronchial asthma confirmed by the physician/chest physician as mentioned in diagnostic criteria; and (2) with symptoms of asthma persisting for at least 6 months despite optimum therapy.

  • Exclusion criteria: (1) history of smoking within the last year; (2) acute infection within the past 6 weeks; (3) people with serious systemic illness, i.e. hepatic, renal, cardiac, or central nervous system disease; (4) people with cardiovascular diseases including hypertension.

  • No. of participants: 71

  • Age (years) (range, mean/median): not reported. All were adults.

  • Female (%): 0

  • White (%): not reported

  • Mean duration of asthma: > 6 months

  • Severity of asthma: not reported

Interventions

Participants were initially stabilised on drugs until no further symptomatic improvement occurred. Then:

  • Yoga group (n = 37): Performed Bhastrika for 15 min daily for 6 weeks along with standard care (the normal medication). The participants inhaled and exhaled forcefully at a ratio of 1:1 for 15 to 20 min with a rest after every 1 min.

  • Control group (n = 34): Standard care (the normal medication) alone

Outcomes

  • Outcome(s): FEV1, FVC, FEV1/FVC ratio

  • Assessment time point(s): 6 weeks

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. Although lung function (FEV1, FVC, and FEV1/FVC ratio) may be more determined by the biological, objective effects of the intervention and therefore less likely to be affected by the participants' and/or personnel's knowledge of the assignment status, we still considered this study to be at high risk of performance bias

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

The paper did not mention any procedures intended to blind outcome assessors. Even if no blinding was applied, assessment of lung function by spirometry is less likely to be biased by outcome assessors' awareness of the intervention status. For this reason we judged this study to be low risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Table 1 indicates no withdrawal or loss to follow‐up

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

Low risk

No evidence of other bias was found

Singh 1990

Methods

  • Country: United Kingdom

  • Setting: Respiratory Medicine Unit, City Hospital

  • Design: a randomised, double‐blind, placebo‐controlled, cross‐over trial

Participants

  • Inclusion criteria: non‐smoking, with mild asthma controlled with inhaled beta2 agonists alone, and had had no symptoms of respiratory tract infection within the previous 6 weeks.

  • Exclusion criteria: not reported.

  • No. of participants: 22

  • Age (years) (range, mean/median): 19 to 54, not reported

  • Female (%): not reported

  • White (%): 100

  • Mean duration of asthma: not reported

  • Severity of asthma: mild

Interventions

Yoga group (n = 22): 15 minutes twice daily for 2 weeks of Pink City Lung Exerciser use

  • inhaled beta2 agonists use was allowed

Control group (n = 22): 15 minutes twice daily for 2 weeks of placebo Pink City Lung Exerciser use

  • inhaled beta2 agonists use was allowed

Outcomes

  • Outcome(s): rescue inhaler use, asthma symptom score, FEV1, PEFR, PD20, adverse events

  • Assessment time point(s): 2 weeks

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

This is a randomised, double‐blind, placebo‐controlled trial

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

The paper did not mention any procedures intended to blind the outcome assessors. However, even if no blinding was applied, assessments of lung function by spirometry and adverse events are less likely to be biased by outcome assessors' knowledge of the assignment status, and the participants, who were unaware of assignment status, were the outcome assessors for the other measures, such as symptom score

Incomplete outcome data (attrition bias)
All outcomes

Low risk

The 4 participants who withdrew from the study were not included in the analysis. However, compared to the sample size of 44, the drop‐out rate was low; we thus considered the risk of bias arising from this issue as low. Quote: "4 subjects withdrew from the study; 1 found the lung exercises to be inconvenient and had nausea during the first period (with the placebo exerciser), and 3 had respiratory tract infection during the second period (2 with the PCL exerciser). Complete data are presented for 18 subjects."

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

Low risk

No evidence of other bias was found

Singh 2012

Methods

  • Country: India

  • Setting: Department of Physiology, University College of Medical Sciences, Delhi

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: Non‐smokers, age 18 to 60 years with mild‐to‐moderate grades of bronchial asthma as per GINA (Global Initiative for Asthma) guidelines (mild: FEV1 > 80% predicted; moderate: FEV1 = 60% to 80% predicted) were included.

  • Exclusion criteria: People with a history of an exacerbation or respiratory tract infections, current smokers, pregnant or lactating women, or people with any other disorder were excluded.

  • No. of participants: 60

  • Age (years): 18 to 60 (mean/median not reported)

  • Female (%): not reported

  • White (%): not reported

  • Mean duration of asthma: > 1 year

  • Severity of asthma: mild to moderate

Interventions

The medication for asthma was kept same throughout the study period.

Yoga group (n = 30): 50 minutes daily for 2 months of yoga (breathing, postures, meditation, and lifestyle modification)

  • pranayama: 30 to 35 minutes

  • asanas: 10 minutes

  • meditation: 10 minutes

  • lifestyle modification

Control group (n = 30): usual care

Outcomes

  • Outcome(s): quality of life (AQLQ, SGRQ), FVC, FEV1, FEV1/FVC ratio, MVV, SVC, PEFR

  • Assessment time point(s): 8 weeks

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. The participants' knowledge of the assignment status could subconsciously affect their quality of life and to a lesser extent their performance in lung function tests

Blinding of outcome assessment (detection bias)
All outcomes

High risk

The paper did not mention any procedures intended to blind the outcome assessment. Assessment of lung function by spirometry was less likely to be biased by the outcome assessors' knowledge of the assignment status, while the participant, who was aware of group assignment, is the outcome assessor for quality of life. Overall, we assessed this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

The 4 participants who withdrew from the study were not included in the analysis. However, compared to the sample size of 60, the 4 excluded participants represented a small number and were thus unlikely to exert substantial influence on the results

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

High risk

There were a number of 'errors' in the paper. For example, the abstract and methods reported that there were 60 participants in total. However, the results section reported that "four subjects withdrew from the study; one found the lung exercises to be inconvenient, and three had respiratory tract infection. Hence complete data are presented for 60 subjects", indicating there should be 64 participants in total. On the other hand, table 1 indicated that there were only 30 participants in total

Sodhi 2009

Methods

  • Country: India

  • Setting: Departments of Medicine and Physiology, Christian Medical College & Hospital, Ludhiana

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: Non‐smokers age 17 to 50 years with mild‐to‐moderate grades of bronchial asthma as per National Asthma Education and Prevention Programme (NAEPP) were included.

  • Exclusion criteria: People with a history of tuberculosis, chronic obstructive pulmonary disease, diabetes, renal failure, coronary artery disease, and musculoskeletal chest deformities; respiratory tract infections within the previous 6 weeks; and engagement in any regular exercise/training were excluded.

  • No. of participants: 120

  • Age (years) (range, mean/median): 17 to 50, 37

  • Female (%): 41

  • White (%): not reported

  • Mean duration of asthma: 7.7 years in yoga and 6.6 years in control group

  • Severity of asthma: mild to moderate

Interventions

All participants remained on their prescribed treatment during the study.

  • Yoga group (n = 60): 45 minutes per week for 8 weeks of yoga, including pranayamas (deep breathing exercises), kapalabhati (cleansing breath), bhastrika (rapid and deep respiratory movements known as 'bellows breath'), ujjayi (loud sound‐producing pranayama), and sukha purvaka pranayama (easy comfortable breathing). Participants were instructed to practice the exercise 45 minutes at home twice daily on all days of the week.

  • Control group (n = 60): not reported

Outcomes

  • Outcome(s): PEFR, FEV1, FVC, FEV1/FVC ratio, FEF 25‐75%

  • Outcome(s): quality of life (AQLQ), asthma attacks per week, medication use, severity of asthma attacks

  • Assessment time point(s): 4, 8 weeks

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. The participants' knowledge of the assignment status could subconsciously affect their quality of life and asthma medication usage, and to a lesser extent the frequency and severity of asthma attacks and performance on lung function tests

Blinding of outcome assessment (detection bias)
All outcomes

High risk

No procedures intended to blind outcome assessment were mentioned. The assessments of lung function by spirometry were less likely to be affected by outcome assessors' knowledge of the assignment status, but for participant‐reported outcomes, such as quality of life and attacks per week, the participant, who was aware of group assignment, was the outcome assessor. Overall, we judged this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

The paper mentioned nothing about withdrawal or loss to follow‐up of participants

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

Low risk

No evidence of other bias was found

Vedanthan 1998

Methods

  • Country: United States

  • Setting: the allergy and asthma clinic at the Hartshorn Health Center of Colorado State University, Fort Collins, Colorado

  • Design: a randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: 17 students with documented asthma, based upon spirometry data of improvement of FEV1 values by at least 20% after bronchodilator inhalation, volunteered for this study.

  • Exclusion criteria: There were no smokers in either the control or yoga group.

  • No. of participants: 17

  • Age (years) (range, mean/median): 19 to 52, 27

  • Female (%): 53

  • White (%): not reported

  • Mean duration of asthma: not reported

  • Severity of asthma: mild to moderate

Interventions

Yoga group (n = 9): 55‐minute classes 3 times weekly for 16 weeks of yoga

  • breathing techniques: 5 minutes

  • loosening exercises: 5 minutes

  • yoga postures: (a) general yogasanas postures: 20 minutes; (b) corpse posture (savasana): 10 minutes

  • breath‐slowing techniques (pranayama): 10 minutes

  • meditation and discussion based on yoga philosophy and yoga therapy: 15 minutes

  • The participants were given audio cassettes and written information to continue the practice at their residences.

Control group (n = 8): not reported

Outcomes

  • Outcome(s): inhalers, steroids, antihistamines, and theophylline use; severity and frequency score; PEFR, FVC, FEV1, FEF 25‐75%

  • Assessment time point(s): 4, 6 weeks

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

No active control. In this case, the participants' knowledge of the assignment status could subconsciously affect their asthma medication usage and severity and frequency scores and to a lesser extent their performance in lung function tests

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Quote: "During the study period, the records of both groups were coded. Decoded data were unavailable to the principal investigators. The investigating physicians did not know which patients were undergoing the yoga intervention." For objective outcomes such as lung function, we considered this study to be at lower risk of bias, but for participant‐reported outcomes we considered the study to be at high risk of bias. Overall, we judged this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All 17 participants completed the study, and there were no dropouts

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

Low risk

No evidence of other bias was found

Vempati 2009

Methods

  • Country: India

  • Setting: the Integral Health Clinic of the All India Institute of Medical Sciences

  • Design: an open‐label randomised, controlled, parallel‐group trial

Participants

  • Inclusion criteria: (1) age 18 years or older; (2) an established diagnosis of mild‐to‐moderate asthma for at least 6 months; (3) taking at least 1 of the following: inhaled beta agonists, methylxanthines, anticholinergics, inhaled corticosteroids; and (4) stable medication dosing for the past month.

  • Exclusion criteria: (1) smoked currently (or in the past year) or had a smoking history of greater than 5 pack‐years; (2) had a concomitant lung disease; (3) were taking leukotriene inhibitors or receptor antagonists, or mast cell‐stabilising agents for at least 6 months; (4) practiced yoga or any other similar discipline during 6 months preceding the study; (5) were pregnant; (6) had a chronic medical condition that required treatment with oral or systemic corticosteroids in the past month; (7) had a medical condition that contraindicated exercise; or (8) had an unstable medical condition.

  • No. of participants: 60

  • Age (years) (range, mean/median): > 18, 33.5

  • Female (%): 42

  • White (%): not reported

  • Mean duration of asthma: 11.6 years in yoga group and 10.5 in control group

  • Severity of asthma: mild to moderate

Interventions

Yoga group (n = 30): a comprehensive yoga‐based lifestyle modification and stress management program for 4 hours a day for 2 weeks, in addition to conventional care (including normal rescue medication use).

  • The program consisted of lectures and practical sessions on asanas (postures), pranayamas (breathing techniques), kriyas (cleansing techniques), meditation, and shavasana (a relaxation technique).

  • The 4‐hour sessions included asanas and pranayamas for 1 hour; breakfast and building up of group support for 30 min; lecture and discussion for 2 hours; and meditation for 30 min.

Control group (n = 30): a session on health education relevant to their illness, in addition to conventional care (including normal rescue medication use)

Outcomes

  • Outcome(s): rescue medication use, AQOL, FEV1, FVC, FEV1/FVC ratio, PEFR, FEF25‐75%

  • Assessment time point(s): 2, 4, 8 weeks

Notes

1 participant in the yoga group and 2 participants in the control group discontinued midway in the study. The results presented in this report are based only on the data collected from the 57 participants who completed the study

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information on random sequence generation was provided

Allocation concealment (selection bias)

Unclear risk

No information on allocation concealment was provided

Blinding of participants and personnel (performance bias)
All outcomes

High risk

This is an open‐label RCT. In this case, the participants' knowledge of the assignment status could subconsciously affect their quality of life and asthma medication usage and to a lesser extent their performance on lung function tests

Blinding of outcome assessment (detection bias)
All outcomes

High risk

This is an open‐label RCT. The reporting and/or evaluation of quality of life and asthma medication use could thus be subconsciously affected by participant's and/or outcome assessors' knowledge of the assignment status. Lung function measures may be less vulnerable to detection bias, but overall we assessed this study to be at high risk of detection bias

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Quote: "However, one subject in the yoga group, and two subjects in the control group discontinued midway in the study. The results presented in this report are based on the data collected from only the 57 subjects who completed the study (yoga group, n = 29; control group, n = 28)." However, compared to the sample size of 60, the drop‐out rate was low. We thus considered the risk of bias arising from this issue to be low

Selective reporting (reporting bias)

Low risk

All study outcomes were reported with details

Other bias

Low risk

No evidence of other bias was found

AQLQ: Asthma Quality of Life Questionnaire
AQOL: Assessment of Quality of Life
FEF 25‐75%: forced expiratory flow between 25% and 75% of vital capacity
FEV1: forced expiratory volume in one secondFRC: functional residual capacity
FVC: forced vital capacity
MVV: maximal voluntary ventilation
PCLE: Pink City Lung Exerciser
PD20: provocative dose of inhaled histamine or methacholine required to produce a 20% fall in FEV1
PEFR: peak expiratory flow rate
RCT: randomised controlled trial
Rtot: total airway resistance
RV: residual volume
SF‐36: 36‐item Short Form Health Survey
SGRQ: St. George's Respiratory Questionnaire
SVC: slow vital capacity
TLC: total lung capacity
VC: vital capacity

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Agnihotri 2014

The outcome measure (biochemical profile) in this report is not relevant to this review. The results on outcomes relevant to the present review were reported by Kant 2013, which has already been included

Chen 2009

It is not a randomised study

Cowie 2008

The intervention (Buteyko technique) is not yogic

Holloway 2007

The intervention (Papworth method) is not yogic

Jain 1991

It is not a randomised study

Khanam 1996

It is not a randomised study

Khare 1991

It is not a randomised study

Kligler 2011

The intervention included nutritional manipulation, yoga techniques, and journaling, and the net comparison of intervention vs control was not yoga alone

Manocha 2002

The control group received relaxation methods, group discussion, and cognitive behaviour therapy, and the net comparison of intervention vs control was not yoga alone

Sathyaprabha 2001

It is not a randomised study

Saxena 2009

The control group practiced meditation, and the net comparison of intervention vs control was not yoga alone

Tahan 2014

It is not a randomised study

Data and analyses

Open in table viewer
Comparison 1. Yoga vs usual care/sham intervention

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Change in AQLQ score Show forest plot

5

375

Mean Difference (IV, Fixed, 95% CI)

0.57 [0.37, 0.77]

Analysis 1.1

Comparison 1 Yoga vs usual care/sham intervention, Outcome 1 Change in AQLQ score.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 1 Change in AQLQ score.

1.1 Yoga breathing alone vs. control

2

196

Mean Difference (IV, Fixed, 95% CI)

0.46 [0.23, 0.69]

1.2 Combination of yoga breathing, postures and meditation vs. control

3

179

Mean Difference (IV, Fixed, 95% CI)

0.85 [0.47, 1.22]

2 Asthma symptom Show forest plot

3

218

Std. Mean Difference (Fixed, 95% CI)

0.37 [0.09, 0.65]

Analysis 1.2

Comparison 1 Yoga vs usual care/sham intervention, Outcome 2 Asthma symptom.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 2 Asthma symptom.

3 FEV1 Show forest plot

10

583

Std. Mean Difference (Random, 95% CI)

0.31 [‐0.08, 0.70]

Analysis 1.3

Comparison 1 Yoga vs usual care/sham intervention, Outcome 3 FEV1.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 3 FEV1.

4 FEV1 change from baseline Show forest plot

7

340

Mean Difference (IV, Random, 95% CI)

0.04 [‐0.10, 0.19]

Analysis 1.4

Comparison 1 Yoga vs usual care/sham intervention, Outcome 4 FEV1 change from baseline.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 4 FEV1 change from baseline.

5 FVC Show forest plot

6

376

Std. Mean Difference (Random, 95% CI)

0.67 [0.20, 1.14]

Analysis 1.5

Comparison 1 Yoga vs usual care/sham intervention, Outcome 5 FVC.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 5 FVC.

6 FEV1/FVC Show forest plot

6

435

Mean Difference (IV, Random, 95% CI)

0.62 [‐1.63, 2.87]

Analysis 1.6

Comparison 1 Yoga vs usual care/sham intervention, Outcome 6 FEV1/FVC.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 6 FEV1/FVC.

7 PEFR Show forest plot

7

455

Std. Mean Difference (Random, 95% CI)

0.73 [0.36, 1.09]

Analysis 1.7

Comparison 1 Yoga vs usual care/sham intervention, Outcome 7 PEFR.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 7 PEFR.

8 FEF25‐75% Show forest plot

3

197

Std. Mean Difference (Random, 95% CI)

0.45 [‐0.28, 1.19]

Analysis 1.8

Comparison 1 Yoga vs usual care/sham intervention, Outcome 8 FEF25‐75%.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 8 FEF25‐75%.

9 Medication usage (frequency) Show forest plot

3

228

Std. Mean Difference (Fixed, 95% CI)

0.69 [0.41, 0.96]

Analysis 1.9

Comparison 1 Yoga vs usual care/sham intervention, Outcome 9 Medication usage (frequency).

Comparison 1 Yoga vs usual care/sham intervention, Outcome 9 Medication usage (frequency).

10 Medication usage (percentage of participants with decreasing dosage) Show forest plot

2

48

Risk Ratio (M‐H, Fixed, 95% CI)

5.35 [1.29, 22.11]

Analysis 1.10

Comparison 1 Yoga vs usual care/sham intervention, Outcome 10 Medication usage (percentage of participants with decreasing dosage).

Comparison 1 Yoga vs usual care/sham intervention, Outcome 10 Medication usage (percentage of participants with decreasing dosage).

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 1

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Study flow diagram.
Figuras y tablas -
Figure 2

Study flow diagram.

Forest plot of comparison: 1 Yoga vs usual care/sham intervention, outcome: 1.1 Change in AQLQ score [7 pt scale].
Figuras y tablas -
Figure 3

Forest plot of comparison: 1 Yoga vs usual care/sham intervention, outcome: 1.1 Change in AQLQ score [7 pt scale].

Forest plot of comparison: 1 Yoga vs usual care/sham intervention, outcome: 1.2 Asthma symptom.
Figuras y tablas -
Figure 4

Forest plot of comparison: 1 Yoga vs usual care/sham intervention, outcome: 1.2 Asthma symptom.

Forest plot of comparison: 1 Yoga vs usual care/sham intervention, outcome: 1.3 FEV1.
Figuras y tablas -
Figure 5

Forest plot of comparison: 1 Yoga vs usual care/sham intervention, outcome: 1.3 FEV1.

Forest plot of comparison: 1 Yoga vs usual care/sham intervention, outcome: 1.4 FEV1 change from baseline [litres].
Figuras y tablas -
Figure 6

Forest plot of comparison: 1 Yoga vs usual care/sham intervention, outcome: 1.4 FEV1 change from baseline [litres].

Comparison 1 Yoga vs usual care/sham intervention, Outcome 1 Change in AQLQ score.
Figuras y tablas -
Analysis 1.1

Comparison 1 Yoga vs usual care/sham intervention, Outcome 1 Change in AQLQ score.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 2 Asthma symptom.
Figuras y tablas -
Analysis 1.2

Comparison 1 Yoga vs usual care/sham intervention, Outcome 2 Asthma symptom.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 3 FEV1.
Figuras y tablas -
Analysis 1.3

Comparison 1 Yoga vs usual care/sham intervention, Outcome 3 FEV1.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 4 FEV1 change from baseline.
Figuras y tablas -
Analysis 1.4

Comparison 1 Yoga vs usual care/sham intervention, Outcome 4 FEV1 change from baseline.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 5 FVC.
Figuras y tablas -
Analysis 1.5

Comparison 1 Yoga vs usual care/sham intervention, Outcome 5 FVC.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 6 FEV1/FVC.
Figuras y tablas -
Analysis 1.6

Comparison 1 Yoga vs usual care/sham intervention, Outcome 6 FEV1/FVC.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 7 PEFR.
Figuras y tablas -
Analysis 1.7

Comparison 1 Yoga vs usual care/sham intervention, Outcome 7 PEFR.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 8 FEF25‐75%.
Figuras y tablas -
Analysis 1.8

Comparison 1 Yoga vs usual care/sham intervention, Outcome 8 FEF25‐75%.

Comparison 1 Yoga vs usual care/sham intervention, Outcome 9 Medication usage (frequency).
Figuras y tablas -
Analysis 1.9

Comparison 1 Yoga vs usual care/sham intervention, Outcome 9 Medication usage (frequency).

Comparison 1 Yoga vs usual care/sham intervention, Outcome 10 Medication usage (percentage of participants with decreasing dosage).
Figuras y tablas -
Analysis 1.10

Comparison 1 Yoga vs usual care/sham intervention, Outcome 10 Medication usage (percentage of participants with decreasing dosage).

Yoga compared with usual care or sham intervention for asthma

Patient or population: People with asthma (mostly mild or moderate)

Settings: Outpatient clinic and at home (studies conducted in Ethiopia, Germany, India, UK, and USA)

Intervention: Yoga (duration no more than 6 months on average; range 2 weeks to 54 months)

Comparison: Usual care or sham intervention

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Usual care or sham intervention

Yoga

Quality of life

(Asthma Quality of Life Questionnaire, with 32 items, 0 to 7 points per item)

The mean points per item of Asthma Quality of Life Questionnaire ranged from 4.06 to 4.50 points across control groups

The mean change from baseline in the intervention groups was on average 0.57 units higher (95% CI 0.37 to 0.77)

375 (5)

⊕⊕⊕⊖

moderate1

Minimal clinically important difference: 0.5

Asthma symptoms

(different severity scores; change from baseline)

The mean severity score ranged from 0.83 to 1.05 points across control groups on different scales

The mean severity score in the intervention groups was on average 0.37 SD units lower (95% CI 0.09 to 0.65)

243 (3)

⊕⊕⊕⊖

moderate2

Lower score indicates improvement

Nagarathna 1985 and Sodhi 2009a used a 3‐point scoring system for severity of asthma symptoms from 1 (mild) to 3 (severe)

Vedanthan 1998 used a 5‐point scoring system from A (no symptoms) to E (very severe symptoms). No established minimal clinically important difference in these scores is available

Asthma control

(weekly number of attacks)

The mean weekly number of attacks ranged cross control groups from 0.58 to 2.10

See comment

226 (2)

⊕⊕⊖⊖

low3

Two studies showed benefit, but the results were not combined due to very high heterogeneity between them

Forced expiratory volume in one second

(change from baseline FEV1 (L))

The mean FEV1 ranged across control groups from 2.24 to 4.19 L

The mean FEV1 in the intervention groups was on average 0.04 L higher (95% CI ‐0.10 to 0.19)

340 (7)

⊕⊖⊖⊖

very low4

Reduced asthma medication usage

8 per 100

43 per 100

(11 to 100)

RR 5.35 (1.29 to 22.11)

48 (2)

⊕⊕⊖⊖

low5

Adverse events

108 (3)

⊕⊖⊖⊖

very low6

Fluge 1994 reported 3 participants from the control group required oral steroids treatment due to acute exacerbations of their asthma, as compared with none in the yoga group. Sabina 2005 reported no adverse events associated with yoga or the control. In Singh 1990, 1 participant in the yoga group reported mild dyspnoea during yoga using the Pink City Lung Exerciser

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; FEV1: forced expiratory volume in one second; RR: risk ratio; SD: standard deviation

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1Downgraded once for study limitations; four out of five studies contributing to this outcome are at high risk of performance and detection bias, and one study is at high risk of attrition bias (see Figure 1).

2Downgraded once for study limitations; all three studies contributing to this outcome are at high risk of performance and detection bias, and one study is at high risk of selection bias (see Figure 1).

3Downgraded for (1) study limitations: both studies contributing to this outcome are at high risk of performance and detection bias, and one study is also at high risk of selection bias (see Figure 1), and (2) inconsistency: the studies could not be combined in a meta‐analysis due to very high levels of heterogeneity.

4Downgraded for (1) study limitations: six out of the seven studies contributing to this outcome are at unclear risk of selection bias (see Figure 1), (2) inconsistency: we detected substantial heterogeneity (I² = 68%) in the meta‐analysis, and (3) imprecision: the confidence intervals include both the possibility of harm or benefit of the intervention.

5Downgraded for (1) study limitations: both studies contributing to this outcome are at high risk of performance and detection bias and at unclear risk of selection bias, and one study is at high risk of other biases (see Figure 1), and (2) imprecision: despite the confidence intervals excluding no difference, the breadth of the confidence intervals and the small numbers of participants in the analysis reduces our confidence in the estimate.

6Downgraded for (1) study limitations: one study reporting adverse events is at high risk of performance, detection, and attrition bias, another is at high risk of attrition and reporting bias, and a third is at unclear risk of selection bias (see Figure 1), (2) imprecision: the very small number of studies reporting very rare events reduced our confidence in this outcome, and (3) potential publication bias due to no mention of adverse events (which were specified explicitly as one of the outcomes of interest in their research protocol) in Prem 2013. We decided not to pool these results.

Figuras y tablas -
Comparison 1. Yoga vs usual care/sham intervention

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Change in AQLQ score Show forest plot

5

375

Mean Difference (IV, Fixed, 95% CI)

0.57 [0.37, 0.77]

1.1 Yoga breathing alone vs. control

2

196

Mean Difference (IV, Fixed, 95% CI)

0.46 [0.23, 0.69]

1.2 Combination of yoga breathing, postures and meditation vs. control

3

179

Mean Difference (IV, Fixed, 95% CI)

0.85 [0.47, 1.22]

2 Asthma symptom Show forest plot

3

218

Std. Mean Difference (Fixed, 95% CI)

0.37 [0.09, 0.65]

3 FEV1 Show forest plot

10

583

Std. Mean Difference (Random, 95% CI)

0.31 [‐0.08, 0.70]

4 FEV1 change from baseline Show forest plot

7

340

Mean Difference (IV, Random, 95% CI)

0.04 [‐0.10, 0.19]

5 FVC Show forest plot

6

376

Std. Mean Difference (Random, 95% CI)

0.67 [0.20, 1.14]

6 FEV1/FVC Show forest plot

6

435

Mean Difference (IV, Random, 95% CI)

0.62 [‐1.63, 2.87]

7 PEFR Show forest plot

7

455

Std. Mean Difference (Random, 95% CI)

0.73 [0.36, 1.09]

8 FEF25‐75% Show forest plot

3

197

Std. Mean Difference (Random, 95% CI)

0.45 [‐0.28, 1.19]

9 Medication usage (frequency) Show forest plot

3

228

Std. Mean Difference (Fixed, 95% CI)

0.69 [0.41, 0.96]

10 Medication usage (percentage of participants with decreasing dosage) Show forest plot

2

48

Risk Ratio (M‐H, Fixed, 95% CI)

5.35 [1.29, 22.11]

Figuras y tablas -
Comparison 1. Yoga vs usual care/sham intervention